Gilead Sciences Inc. (1GILD)
MTA
Closed
Aug 25, 2026
Day's Range
126.7452 wk Range
93.11Overview - 1GILD - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
150.74B
P/E (Trailing)
‪17.80‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪5.08‬
Price / Book
‪15.29‬
EV / EBITDA
‪12.05‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.27%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪114.79‬
200-Day Avg
‪114.65‬
Dividends
Payout Ratio
‪43.40%‬
Frequency
Quarterly
Market Cap - 1GILD - Gilead Sciences Inc.
Peers - 1GILD - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1GILDMTAGilead Sciences Inc.131.15BMarket Cap+21.35%52-week change17.80P/E (Trailing)‪-10.63%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+43.34%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+34.67%52-week change31.56P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+21.59%52-week change75.36P/E (Trailing)‪9.80%‬Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+27.57%52-week change24.74P/E (Trailing)‪19.60%‬Profit Margin
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+44.77%52-week change121.83P/E (Trailing)‪4.76%‬Profit Margin
- 1NOVNMTANovartis AG238.75BMarket Cap+22.16%52-week change24.05P/E (Trailing)‪22.50%‬Profit Margin
Profile Summary - 1GILD - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs in infectious diseases, oncology, and other therapeutic areas across the United States, Europe, and international markets. Its portfolio centers on HIV treatments, including leading…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
